Tech Company Financing Transactions
InxMed Funding Round
InxMed, based in Beijing, raised $15 million in investment from Hyfinity Investments.
Transaction Overview
Company Name
Announced On
5/9/2022
Transaction Type
Venture Equity
Amount
$15,000,000
Round
Series B
Investors
Hyfinity Investments (Lead Investor)
Proceeds Purpose
The company intends to use the funds to accelerate ongoing clinical trials of IN10018 for multiple cancer types in both US and China, including the initiation of pivotal trials in the second half year, and advance more stroma targeting pipelines into clinics in both US and China this year, and strengthen the R&D capabilities in Nanjing.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
79 Jianguo Road, China Central Place Tower 2, Room 3007 Chao
Beijing, 100012
China
Beijing, 100012
China
Phone
Website
Email Address
Overview
Founded in 2018, InxMed is a clinical-stage oncology focused biotech company with a winning strategy of "Best-in-Disease Combination". With disease biology being the source of innovation, the company aims to find solutions for oncology drug resistance and tumor metastasis, especially resistance to anti-PD-1. We are dedicated to researching the tumor microenvironment and building a distinct translational medicine platform with strong proof-of-concept validation capability. We aspire to become a China-based company with global impact.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Zaiqi Wang
Chief Operating Officer
Fei Cao
Browse more venture capital transactions:
Prev: 5/9/2022: Cogniteam venture capital transaction
Next: 5/9/2022: FutureProof venture capital transaction
Share this article
News on VC Transactions
Our team works diligently to report on every notable VC transaction. All VC database entries on this site are derived from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs